Followers | 9841 |
Posts | 260003 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
![](https://investorshub.advfn.com/uicon/89929.png?cb=1464345786)
Tuesday, April 28, 2020 6:13:54 PM
Link to Video - click here to watch the technical chart video
Recent AGLE News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2024 04:15:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/25/2024 08:55:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/25/2024 08:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:21:55 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/01/2024 08:06:29 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/20/2024 11:14:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/18/2024 08:06:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 12:31:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/14/2024 08:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:33:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:36:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:33:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:32:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:27:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:25:02 PM
- Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/23/2023 01:45:06 AM
- Aeglea BioTherapeutics Announces Grants of Inducement Awards • PR Newswire (US) • 11/22/2023 10:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 10:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:14:01 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM